GlassScriptPhysician profile
Deborah A Lenart
NPI 1760581854
$3,353.23
in general payments reported to CMS, 2019-2025
29 companies · $33.10 in 2025
The $33.10 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $296 · 2021: $581 · 2022: $626 · 2023: $1,209 · 2024: $89.18 · 2025: $33.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.65 | 2019-2025 | |
| Daiichi Sankyo INC. | $578.96 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $289.68 | 2022-2023 | |
| Minerva Surgical, INC | $230.04 | 2019-2023 | |
| Evofem Biosciences, INC. | $163.54 | 2021-2022 | |
| Exeltis, USA INC. | $154.95 | 2020-2023 | Slynd |
| Terumo Medical Corporation | $135.67 | 2023 | Azur Cx Detachable |
| Therapeuticsmd, INC. | $128.60 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $123.58 | 2019-2020 | |
| Coopersurgical, INC. | $91.86 | 2019-2022 | |
| Amgen INC. | $81.73 | 2019-2023 | Evenity, Prolia |
| Mylan Pharmaceuticals INC. | $72.27 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $72.16 | 2023 | Myfembree, Gemtesa |
| Ethicon US, LLC | $66.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $66.95 | 2021-2023 | Gardasil 9 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $62.57 | 2021-2023 | |
| Meditrina | $57.48 | 2022 | |
| Agile Therapeutics, INC. | $52.87 | 2021 | |
| Astellas Pharma US INC | $46.79 | 2019-2021 | |
| Myovant Sciences INC. | $36.35 | 2022 | |
| Avion Pharmaceuticals | $22.66 | 2020-2021 | |
| Hologic Sales and Service, LLC | $20.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.14 | 2019 | |
| Covidien LP | $14.94 | 2019 | |
| Mission Pharmacal Company | $14.59 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.33 | 2019 | |
| Medtronic, INC. | $13.22 | 2021 | |
| Currax Pharmaceuticals LLC | $12.56 | 2022 | |
| Acessa Health INC. | $10.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Lenart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.